PPD signed on as preferred provider for Harbour BioMed

By Melissa Fassbender contact

- Last updated on GMT

(Image: Getty/tadamichi)
(Image: Getty/tadamichi)

Related tags: Ppd, CRO, Preferred partnership, Clinical trials

Harbour BioMed has selected PPD as its preferred CRO partner as part of a strategic collaboration to develop novel oncology and immunology therapeutics.

The a global clinical-stage biopharmaceutical company Harbour BioMed (HBM), and contract research organization (CRO), PPD, have today announced a strategic collaboration.

As per the agreement, HBM has selected PPD as its preferred CRO partner to conduct global clinical studies. The companies have worked together previously, recently completing an Australian ethics committee (EC) submission for HBM4003, HBM’s anti-cancer immunotherapy targeting solid tumors.

“Harbour BioMed is leveraging the services of PPD Biotech, which combines the global capabilities of PPD with the hands-on approach, dedication and innovative mindset that drive the success of biotech clients,” ​said Anshul Thakral, executive vice president and global head of PPD Biotech.

“Harbour BioMed’s selection of PPD Biotech as its preferred partner is further evidence that pairing our unique biotech perspective with our scalable global development services is a powerful combination for our customers,”​ he added.

Established in late 2016, HBM’s portfolio includes five clinical-stage, in-licensed compounds as well as therapeutics generated by its internal discovery efforts.  The company also has co-discovery and development collaborations in place with academic institutions and biopharmaceutical companies.

These programs leverage HMB’s two patented transgenic mouse platforms for generating fully human monoclonal antibodies (mAb), which the company also licenses out.

Related news

Show more

Related products

show more

How clinical trial software can optimize trials

How clinical trial software can optimize trials

Formedix | 09-Jun-2021 | Technical / White Paper

This article explains the different types of clinical trial software available, and how it can be used to optimize the end to end clinical trials design...

Adapting supply chains to new ways of working

Adapting supply chains to new ways of working

World Courier | 01-Jun-2021 | Technical / White Paper

COVID-19 has changed the way we operate. We have adapted our supply chain solutions to meet our clients’ requirements while following World Courier standard...

What are the building blocks of DCTs?

What are the building blocks of DCTs?

Medable | 26-Apr-2021 | Technical / White Paper

How to create a seamless experience across eConsent, eCOA and more.

Over the past year, tremendous progress was made toward digitizing and...

How a clinical metadata repository helps with data

How a clinical metadata repository helps with data

Formedix | 22-Mar-2021 | Technical / White Paper

This article covers the various ways a clinical metadata repository helps with data quality, and in turn, with data quality in the clinical trials process....

Related suppliers

Follow us

Products

View more

Webinars